Review of the trends in the pharmaceutical market of eeu and cis countries
The paper contains an overview of the main trends in the regulation of the pharmaceutical market of EEU and CIS countries in the situation of economic crisis development and national currencies devaluation. Due to the high import dependence of the pharmaceutical market, governments of a number of countries introduced strict price regulation not only in the reimbursable, but also commercial part of the market, which creates risks in decreasing the number of medicines represented and their affordability. Despite the difficult economic situation, the healthcare system reforms initiated by many countries, as well as transition to the models of compulsory health insurance are continuing. The joint regulatory environment being formed now is regarded as an important factor for the development of the EEU countries markets. These countries are also carrying out an active government policy of supporting domestic producers and localizing production of foreign pharmaceuticals, which in some cases takes economically ineffective forms.